However, further investigation of the mechanism in the future may help to develop new ways of overcoming the feedback reactivating of the RAS/MAPK pathway in NF1 wild type neuroblastomas to render them sensitive to MEK inhibitors in general. Here, NF1 is linked to neuroblastoma.